(Q30942931)

27 June 2017

1 reference

title

Review article: percutaneous treatment of hepatocellular carcinoma (English)

1 reference

27 June 2017

1 reference

Gaiani S

1

1 reference

27 June 2017

Celli N

2

1 reference

27 June 2017

Cecilioni L

3

1 reference

27 June 2017

Piscaglia F

4

1 reference

27 June 2017

Bolondi L

5

1 reference

27 June 2017

language of work or name

English

0 references

publication date

1 June 2003

1 reference

Alimentary Pharmacology & Therapeutics

27 June 2017

published in

1 reference

27 June 2017

volume

17 Suppl 2

1 reference

27 June 2017

page(s)

103-110

1 reference

Estimating the world cancer burden: Globocan 2000.

27 June 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Clinical management of hepatocellular carcinoma. Conclusions of the Barcelona-2000 EASL conference. European Association for the Study of the Liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Chemoprevention of hepatocellular carcinoma in hepatitis C virus-related cirrhosis: first, eliminate the virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Surveillance programme of cirrhotic patients for early diagnosis and treatment of hepatocellular carcinoma: a cost effectiveness analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Prognostic prediction and treatment strategy in hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Hepatocellular carcinoma and cirrhosis in 746 patients: long-term results of percutaneous ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Guidelines for treatment of liver cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Long-term results of percutaneous ethanol injection therapy for hepatocellular carcinoma in cirrhosis: a European experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Percutaneous ethanol injection of hepatic tumors: single-session therapy with general anesthesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Long term results of single session percutaneous ethanol injection in patients with large hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Combination therapy with transcatheter arterial chemoembolization and percutaneous ethanol injection compared with percutaneous ethanol injection alone for patients with small hepatocellular carcinoma: a randomized control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Small hepatocellular carcinoma: treatment with radio-frequency ablation versus ethanol injection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Radiofrequency ablation of hepatocellular cancer in 110 patients with cirrhosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Radiofrequency ablation and percutaneous ethanol injection in patients with small hepatocellular carcinoma: a comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Hepatocellular carcinoma: radio-frequency ablation of medium and large lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Increased risk of tumor seeding after percutaneous radiofrequency ablation for single hepatocellular carcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Interstitial laser photocoagulation under ultrasound guidance of liver tumors: results in 104 treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Hepatocellular carcinoma: long-term results of combined treatment with laser thermal ablation and transcatheter arterial chemoembolization

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

Tumor dissemination after radiofrequency ablation of hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2036.17.S2.21.X

10.1046/J.1365-2036.17.S2.21.X

21 January 2018

Identifiers

DOI

1 reference

27 June 2017

1 reference